| Gene | MYLK | Organism | Human |
| Genome Locus | chr3:123471177-123512691:- | Build | hg19 |
| Disease | Bladder Cancer | ICD-10 | Malignant neoplasm of Bladder, unspecified (C67.9) |
| DBLink | Link to database | PMID | 28687357 |
| Experimental Method |
| Sample Type | Tissues | Comparison | bladder carcinomas and matched para-carcinomas
|
| Method for Estimation | Quantitative PCR | PCR Details | |
Primers
(Predicted) | Suggested Primers | Statistics | Fold Change : Upregulated
pvalue : p<0.05 |
| Citation |
| Zhong, Z, Huang, M, Lv, M, He, Y, Duan, C, Zhang, L, Chen, J (2017). Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway. Cancer Lett., 403:305-317. |
